Altman Z Score
-11.07
+0.01+0.09%
Wed, 27 Nov 2024 23:24:11 GMT
Summary:
Lexicon Pharmaceuticals altman Z score is currently -11.07, with a rise of +0.01 (+0.09%) during the most recent trading day. Over the past year, it has dropped by -0.79 (-7.68%).LXRX Altman Z Score Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LXRX Altman Z Score Performance
| PeriodPeriod | Altman Z scoreAltman Z score | PricePrice | Market capMarket cap |
|---|---|---|---|
| todaytoday | +0.1% | +0.3% | +0.3% |
| 1 m1 month | -16.2% | -54.3% | -54.3% |
| 3 m3 months | -14.6% | -52.1% | -52.1% |
| 6 m6 months | -13.2% | -49.8% | -49.8% |
| ytdytd | -2.8% | -45.1% | -18.9% |
| 1 y1 year | -7.7% | -26.9% | +7.9% |
| 5 y5 years | -60.9% | -77.0% | -21.8% |
Lexicon Pharmaceuticals Altman Z Score History
| Date | Value |
|---|---|
| 2024 | -11.07(+2.8%) |
| 2023 | -10.77(+12.1%) |
| 2022 | -9.61(+493.2%) |
| 2021 | -1.62(-52.9%) |
| 2020 | -3.44(+273.9%) |
| 2019 | -0.92(-85.3%) |
| 2018 | -6.25(+119.3%) |
| 2017 | -2.85(+143.6%) |
| 2016 | -1.17(-239.3%) |
| 2015 | 0.84(-185.7%) |
| 2014 | -0.98(+92.2%) |
| 2013 | -0.51(-118.1%) |
| Date | Value |
|---|---|
| 2012 | 2.81(+2710.0%) |
| 2011 | 0.10(-128.6%) |
| 2010 | -0.35(-80.1%) |
| 2009 | -1.76(+15.8%) |
| 2008 | -1.52(-191.6%) |
| 2007 | 1.66(-226.7%) |
| 2006 | -1.31(+70.1%) |
| 2005 | -0.77(-153.5%) |
| 2004 | 1.44(+71.4%) |
| 2003 | 0.84(-75.6%) |
| 2002 | 3.44(-79.0%) |
| 2001 | 16.40(-55.8%) |
| 2000 | 37.10 |
FAQ
- What is Lexicon Pharmaceuticals altman Z score?
- What is LXRX altman Z score year-to-date change?
- What is Lexicon Pharmaceuticals altman Z score year-on-year change?
What is Lexicon Pharmaceuticals altman Z score?
The current altman Z score of LXRX is -11.07
What is LXRX altman Z score year-to-date change?
Lexicon Pharmaceuticals altman Z score has changed by -0.30 (-2.79%) since the beginning of the year
What is Lexicon Pharmaceuticals altman Z score year-on-year change?
Over the past year, LXRX altman Z score has changed by -0.79 (-7.68%)